Table 3.
Amino acid or analog | Type of compound | Gap1p activity remaining 2 h after addition, % | Doubling time as a sole nitrogen source, h |
---|---|---|---|
No analog | 100 | 2.9 | |
l-glutamic acid | l-α-amino acid | 3 | 3.2 |
l-cysteine | l-α-amino acid | 2 | >20 |
l-glutamine | l-α-amino acid | 2 | 2.7 |
l-glycine | l-α-amino acid | 6 | >20 |
l-histidine | l-α-amino acid | 1 | >20 |
l-lysine | l-α-amino acid | 18 | >20 |
l-serine | l-α-amino acid | 2 | 3.4 |
l-leucine | l-α-amino acid | 1 | 5.7 |
l-alanine | l-α-amino acid | 2 | 4.7 |
l-aspartic acid | l-α-amino acid | 2 | 3.2 |
l-phenylalanine | l-α-amino acid | 2 | 5.2 |
l-arginine | l-α-amino acid | 8 | 2.9 |
l-threonine | l-α-amino acid | 2 | 6.8 |
l-tyrosine | l-α-amino acid | 2 | 5.6 |
l-tryptophan | l-α-amino acid | 2 | 11.7 |
l-valine | l-α-amino acid | 2 | 4.4 |
l-isoleucine | l-α-amino acid | 2 | 6.1 |
l-methionine | l-α-amino acid | 2 | >20 |
l-asparagine | l-α-amino acid | 2 | 2.8 |
l-citrulline | l-α-amino acid | 7 | 6.9 |
l-ornithine | l-α-amino acid | 11 | 13.4 |
l-proline | Imino acid | 32 | 6.7 |
γ-Methylene-d,l-glutamic acid | l-α-amino acid | 10 | 10.3 |
l-α-aminoadipic acid | l-α-amino acid | 3 | >20 |
l-methionine sulfoximine | l-α-amino acid | 2 | >20 |
l-methionine sulfoxide | l-α-amino acid | 19 | 9.4 |
l-glutamic acid γ-ethyl ester | l-α-amino acid | 7 | 7 |
β-Glutamic acid | β-Amino acid | 24 | >20 |
γ-Aminobutyric acid | γ-Amino acid | 55 | 4.3 |
Allantoin | — | 80 | 3.4 |
N-methylaspartic acid | N-methyl amino acid | 97 | >20 |
N-methylglutamic acid | N-methyl amino acid | 89 | >20 |
l-glutamic acid amide | Amide | 92 | >20 |
Gap1p activity was measured by [14C]citrulline uptake in a PADH1-GAP1-HA strain (CKY759) treated with the indicated amino acid or analog. All amino acids or analogs were dissolved in minimal ammonia medium, adjusted to pH 4, and added to 3 mM in minimal ammonia medium, except that those labeled with * were assayed at 0.75 mM and with ‡ was assayed at 0.5 mM. Assays were performed at least twice, in duplicate. Doubling times were measured for wild-type (CKY443) at 24°C in the presence of 6.8 mM amino acid or analog, the concentration routinely used for glutamate or glutamine minimal medium. All media were adjusted to pH 4. Those labeled with
were assayed for growth rate in the presence of 3 mM analog for solubility reasons and/or to allow comparison between the analogs shown in Figs. 4 and 5B. Also, the sample labeled with
was assayed for growth rate with 2 mM tyrosine for solubility reasons.
, These were at least partially toxic at ≥3 mM. However, cysteine is not toxic at the concentration shown, 0.75 mM.